文献速递颈动脉与弓上血管

颈动脉血运重建术后阿片类药物消耗情况

Opioid Consumption after Carotid Revascularization.
PubMed 文献 · Ann Vasc Surg · 2019-08-30

该回顾性研究评估颈动脉血运重建术后阿片类药物的处方与实际消耗差异。共209例患者,98例(47%)出院时获阿片类处方,处方总量1623片(人均25.4±5.5片),实际消耗仅336片(人均5.3±1.1片),未消耗1287片(79%)。结论认为颈动脉血运重建术后减少阿片类处方或可行。

要点

  • 颈动脉血运重建术后阿片类处方量远高于实际消耗量。
  • 人均处方25.4±5.5片,实际仅消耗5.3±1.1片。
  • 79%的处方药片未被消耗,提示可减少处方。

核心结论

  • 颈动脉血运重建术后患者实际消耗的阿片类药物远少于处方量,减少处方可能可行。

研究设计与样本

  • 回顾性综述,评估颈动脉血运重建术后出院阿片类处方习惯,纳入获阿片类处方的患者。
  • 共209例患者可纳入,平均年龄68岁,白人98%,男性58%。
  • 手术包括颈动脉内膜切除术(CEA)占75%和经颈动脉血运重建术(TCAR)占25%。
  • 98例(47%)患者出院时获阿片类处方,8例排除分析(3例既往阿片类使用,5例拒绝参与)。
  • 约71%患者参与电话调查,确定处方药片消耗情况。

主要发现

  • 共处方1623片阿片类药物(人均25.4±5.5片),实际消耗336片(人均5.3±1.1片)。
  • 约1287片(占总处方79%)未被消耗。

临床怎么用

  • 颈动脉血运重建术后可考虑减少阿片类药物出院处方量,以降低剩余药片和滥用风险。

局限性

  • 本研究为回顾性设计,依赖患者电话调查自报消耗量,可能存在回忆偏倚。
  • 样本以白人男性为主,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioid overdose is now the leading cause of injury-related death in the United States. Overprescription of opioids is one factor contributing to this epidemic. Previous studies demonstrated an overprescription of opioids compared with patient consumption after general surgery procedures. The objective of this study is to evaluate opioid consumption after carotid revascularization. METHODS: This is a retrospective review of the opioid-prescribing habits after discharge of carotid revascularization. Patients who were documented to receive an opioid prescription were included in the study. A phone survey was conducted to determine patient consumption of the prescribed pills. Surgical procedures include carotid endarterectomy (CEA) and transcarotid arterial revascularization (TCAR). The primary outcome is the difference between opioids prescribed and opioids consumed. RESULTS: There were 209 patients available for inclusion. The mean age was 68 years with white (98%) males (58%) making up most patients. CEA and TCAR accounted for 75% and 25% of cases, respectively. About 98 (47%) patients were prescribed opioids after discharge. Eight were excluded from analysis (3 for prior opioid use and 5 declined participation). About 71% of patients participated in the survey. A total of 1,623 pills were prescribed (25.4 ± 5.5 per patient), but only 336 pills were consumed (5.3 ± 1.1 per patient). About 1,287 (79% of total) pills were not consumed. CONCLUSIONS: These data are the first to compare opioid prescription with opioid consumption after carotid revascularization. We demonstrate that patients consume much less opioids than prescribed. These findings indicate that a reduction in opioid prescriptions may be possible after carotid revascularization.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Balceniuk MD, Zhao P, Chu IV, et al. Opioid Consumption after Carotid Revascularization. Ann Vasc Surg. 2019. PMID: 31476423. doi:10.1016/j.avsg.2019.08.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。